Jump to main content
Jump to site search

Issue 60, 2016, Issue in Progress
Previous Article Next Article

LPA1 extracellular loop residues 115 and 191 are not required for receptor activation but prevent Ki16425 super-antagonism

Author affiliations

Abstract

Lysophosphatidic acid receptor 1 (LPA1) is a clinically important target, which confers a biological response to lysophosphatidic acid-type agonists. Recently, the 3D structure of LPA1 resolved using X-ray crystallography and our site-directed mutagenesis has provided significant insight into the mechanism of LPA1 activation and antagonism. In the present study, we report that extracellular loop residues (R115 and D191) are not required for receptor activation but repress Ki16425-type super-antagonism but not LPA-analogue antagonists using a combination of site-directed mutagenesis and intracellular calcium assay procedures. The underlying mechanism was further queried using an all-atom molecular dynamics (MD) simulation. The result showed that Ki16425 when bound to LPA1 evolved characteristic conformational and optimal route communication signatures as a LPA (C18:1)-agonist which is reversed in R115A and D191A mutants. In conclusion, Ki16425 is a super-antagonist when bound to mutant (R115A and D191A) LPA1.

Graphical abstract: LPA1 extracellular loop residues 115 and 191 are not required for receptor activation but prevent Ki16425 super-antagonism

Back to tab navigation

Supplementary files

Publication details

The article was received on 19 Feb 2016, accepted on 18 May 2016 and first published on 20 May 2016


Article type: Paper
DOI: 10.1039/C6RA04276G
Citation: RSC Adv., 2016,6, 55257-55265
  •   Request permissions

    LPA1 extracellular loop residues 115 and 191 are not required for receptor activation but prevent Ki16425 super-antagonism

    O. I. Omotuyi, D. D. Adebowale, A. Famuti and H. Tsuyoshi, RSC Adv., 2016, 6, 55257
    DOI: 10.1039/C6RA04276G

Search articles by author

Spotlight

Advertisements